According to the complaint the plaintiff alleges on behalf of purchasers Dynavax Technologies Corporation …
Deadline
Dynavax Technologies is having an incredible day in the market today, and for good reason. Early this morning, the company announced that it has received anticipated requests from the US FDA for more information with …
Stock
This is a proprietary realized volatility rating created by Capital Market Laboratories (CMLviz) based on a large number of data interactions for Dynavax Technologies Corporation (NASDAQ:DVAX) . We examine the little …
Looking back to 165 days ago, Dynavax Technologies Corp (Symbol: DVAX) priced a 79,570,000 share secondary stock offering at $1.08 per share. Buyers in that offering made a considerable investment into the …
NASDAQ
Investors in shares of Dynavax Technologies Corporation DVAX need to pay close attention to the stock based on moves in the options market lately. That is because the Call which expires on Jan 20, 2017 for the $13 strike …
Spike
After a long debate, Dynavax Technologies Corporation’s (NASDAQ:DVAX) hepatitis B vaccine Heplisav ended …
Cowen and Company set a $45.00 price objective on Dynavax Technologies Corp. (NASDAQ:DVAX) in a research note published on Friday. The brokerage currently has a buy rating on the biopharmaceutical company’s …
After completing a thorough study on Dynavax Technologies Corporation (NASDAQ:DVAX) fundamentals and technical, the Wall Street analysts have given its stock a price target of $47. This estimate is the result of …
DVAX stock has a market capitalization of $176.93 Million. The company beat the analyst EPS Estimate with the difference of $-0.15. The current share price indicate that stock is -84.43% away from its one year high and is …
Shares of Dynavax Technologies Corporation (NASDAQ:DVAX) are showing high volatlity in today’s session as the stock has moved -62.84%, clocking in at $4.31 after a recent bid. Volatility is the dispersion of returns for …
NASDAQ